Advertisement
Dentistry
Subscribe to Dentistry
View Sample

FREE Email Newsletter

Aerotel to Present Mobile Health and Telemedicine Solutions at Mobile World Congress 2011

February 8, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

BARCELONA, Spain, Feb. 8, 2011 /- Aerotel Medical Systems , a leading global supplier of advanced remote monitoring solutions for telehealth and telecare, will showcase its mobile health (mHealth) and other telemedicine solutions at the Mobile World Congress (MWC) 2011 in Barcelona, Spain...

Symmetry Medical to Host Investor Breakfast on February 17, 2011

February 8, 2011 5:35 am | by Bio-Medicine.Org | News | Comments

WARSAW, Ind., Feb. 8, 2011 /- Symmetry Medical Inc. (NYSE: SMA ), a leading independent provider of products to the global orthopaedic device industry and other medical markets, announced today that the Company will host an Investor Breakfast on Thursday, February 17, 2011 at 7:30 a.m....

Henry Schein to Webcast Fourth Quarter 2010 Conference Call Tuesday, February 22, at 10:00 a.m. EST

February 8, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

MELVILLE, N.Y., Feb. 8, 2011 /- Henry Schein, Inc. (Nasdaq: HSIC ), the largest provider of health care products and services to office-based practitioners, announced today that it will release its fourth quarter 2010 financial results before the stock market opens on Tuesday, February...

Advertisement

FDA Orders Postmarket Surveillance of Certain TMJ Implants

February 7, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Feb. 7, 2011 /PRNewswire-USNewswire/ -- Today the U.S. Food and Drug Administration ordered three manufacturers of temporomandibular joint (TMJ) implants to conduct postmarket surveillance studies to determine the length of time before the implants are removed or...

Henry Schein to Present at the UBS 21st Annual Global Healthcare Services Conference

February 7, 2011 3:33 am | by Bio-Medicine.Org | News | Comments

MELVILLE, N.Y., Feb. 7, 2011 /- Henry Schein, Inc., (Nasdaq: HSIC ), the largest provider of health care products and services to office-based practitioners, announced today that Stanley M. Bergman, Chairman and Chief Executive Officer of Henry Schein, and Steven Paladino, the Company's...

Young Innovations, Inc. Provides 4th Quarter Conference Call Details

January 27, 2011 1:34 pm | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Jan. 27, 2011 /- Young Innovations, Inc. (Nasdaq: YDNT ) today announced that it will broadcast its fourth quarter earnings results with a live and on-demand web cast conference call on Thursday, February 3, 2011 at 11:00 a.m. Central Time. A live audio broadcast of the call...

Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2011 Results

January 21, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

GLENWOOD, Ill., Jan. 21, 2011 /- Landauer, Inc. (NYSE: LDR ), will release financial results for the fiscal first quarter of 2011 pre-market on Tuesday, February 1, 2011. The company will host a conference call for investors on Tuesday, February 1, 2011, at 2:00 p.m. Eastern Time....

Reportlinker Adds Dental Implants and Biomaterials - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

January 20, 2011 3:39 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Jan. 20, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Dental Implants and Biomaterials - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016...

Advertisement

Nonin Medical, Inc. Launches New WristOx2â„¢, Model 3150 in U.S. and Canada

January 19, 2011 10:38 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Jan. 19, 2011 /- Nonin Medical, Inc., the inventor of fingertip pulse oximetry and an innovator of noninvasive physiological monitoring solutions, today announced the United States and Canadian launches of its WristOx2™, Model 3150 wrist-worn pulse oximeter. (Photo:...

Zimmer Holdings Announces Live Audio Webcast and Conference Call of Fourth Quarter and Year End 2010 Results

January 14, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

WARSAW, Ind., Jan. 14, 2011 /- Zimmer Holdings, Inc. (NYSE and SIX: ZMH) announced today its fourth quarter 2010 sales and earnings conference call will be broadcast live over the Internet on Thursday, January 27, 2011, at 8:00 a.m. Eastern Time.  A news release detailing the...

$1,700,000 Funding of NeoStem's Very Small Embryonic-Like Stem Cells Being Developed to Treat Osteoporosis Recommended by the Department of Defense Peer Reviewed Medical Resea...

January 13, 2011 4:37 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Jan. 13, 2011 /- NeoStem, Inc. (NYSE Amex: NBS ) ("NeoStem" or the "Company"), an international biopharmaceutical company with operations in the U.S. and China, today announced that its FY2010 Technology/Therapeutic Development Award application number PR101055 has been...

Allegiance Health in Michigan Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service

January 13, 2011 4:37 am | by Baxter | News | Comments

CHICAGO, Ill. - January 13, 2011 - In honor of its broad-based efforts to improve the lives of the most vulnerable members of its community, Allegiance Health in Jackson, Mich., is the recipient of the 2010 Foster G. McGaw Prize for Excellence in Community Service, one of the most esteemed commun

Water Street Healthcare Partners Acquires OraPharma, Inc.

January 5, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

CHICAGO, Jan. 5, 2011 /- Water Street Healthcare Partners announced today that it has acquired OraPharma, Inc. from Johnson & Johnson.  Water Street, a strategic private equity firm focused exclusively on health care, plans to build OraPharma into a leading specialty...

Advertisement

Edge EHR Corp. Announces edgeDMS for iPad, Native Touch-Based Clinical Charting Software for the Paperless Dental Office.

December 22, 2010 2:34 am | by Bio-Medicine.Org | News | Comments

SEATTLE,  Dec. 22, 2010 /- Edge EHR Corp., EDGE, a provider of Dental  Practice Management solutions for the Mac OS®, is pleased to announce the release of edgeDMS™ for iPad® for Dentists and Dental offices looking to leverage the awesome power of...

Mesa Labs Acquires the Biological Indicators Business of Apex Laboratories, Inc.(2)

December 21, 2010 5:34 pm | by Bio-Medicine.Org | News | Comments

LAKEWOOD, Colo., Dec. 21, 2010 /- Mesa Laboratories, Inc. (Nasdaq: MLAB ), a Lakewood, Colorado based manufacturer of electronic instruments and disposables today announced the acquisition of the biological indicators business of Apex Laboratories, Inc., a North Carolina based company....

Zimmer Holdings to Present at 29th Annual J.P. Morgan Healthcare Conference

December 16, 2010 4:35 pm | by Bio-Medicine.Org | News | Comments

WARSAW, Ind., Dec. 16, 2010 /- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal care, announced that it will be participating in the 29th Annual J.P. Morgan Healthcare Conference in San Francisco, California, on January 10, 2011, at 12 p.m. Eastern Time. A...

Sage Products and 3M Infection Prevention Announce Agreement

December 15, 2010 5:32 am | by Bio-Medicine.Org | News | Comments

CARY, Ill. and ST. PAUL, Minn., Dec. 15, 2010 /- Sage Products, Inc. and the 3M Infection Prevention Division have entered into an agreement in which Sage Products will purchase pre-filled, single dose bottles of 3M™ Peridex™ Oral Rinse for its Q-Care® Rx systems,...

Reportlinker Adds European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering 2011

December 14, 2010 9:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 14, 2010 /- Reportlinker.com announces that a new market research report is available in its catalogue: European Markets for Dental Bone Graft Substitutes, Dental Membranes and Tissue Engineering 2011...

Zoledronic Acid Did Not Improve Disease Free Survival in Early Breast Cancer

December 9, 2010 9:33 am | by AACR | News | Comments

SAN ANTONIO - Zoledronic acid did not improve disease free survival among women with stage II/III breast cancer according to results of the Adjuvant Treatment with Zoledronic Acid in Stage II/III Breast Cancer (AZURE) trial, which was presented at the 33rd Annual CTRC-AACR San Antonio...

Research Shows That We Fail To Act On Warning Signs That Could Indicate Major Health Issues

December 2, 2010 10:32 pm | by RealWire | News | Comments

Britons have become so desensitised to warning signs that they regularly place themselves in dangerous situations and put off dealing with health issues, Dr Glenn Wilson a prominent psychologist cautioned today. The Blasé Britain report launched by Corsodyl lays bare the true extent...

Genetics spurs next generation of brain research

November 3, 2010 9:35 pm | by Baylor College of Medicine | News | Comments

The field of neurogenetics soared during the decade since scientists first released a draft sequence of the human genome, said leaders in the field from Baylor College of Medicine and Emory University School of Medicine in Atlanta in an overview published in the current issue of the...

LitePoint Joins Continua Health Alliance

November 1, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Nov. 1, 2010 /- LitePoint Corporation, the leader in wireless test solutions, announced today it has joined Continua Health Alliance, along with other technology leaders. The alliance's mission is to improve the quality of personal healthcare and to establish a system...

Neighborhood House, Health Center Team Up

October 29, 2010 9:33 am | by San Diego Business Journal | News | Comments

Two San Diego community organizations are joining forces to enhance health care assistance to 8,000 San Diego County preschool children.

Henry Schein Reports Record Third Quarter Results

October 29, 2010 3:33 am | by Bio-Medicine.Org | News | Comments

MELVILLE, N.Y., Oct. 29 /- Henry Schein, Inc. (Nasdaq: HSIC ), the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended September 25, 2010. Net sales for the third quarter of 2010 were $1.9...

Study Confirms Passive Safety Devices Are Most Effective in Needlestick Injury Prevention

October 26, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

BETHLEHEM, Pa., Oct. 26 /- A landmark study of 22 million safety devices used in 61 French hospitals over a two-year period has confirmed the theory that passive, fully automatic safety devices offer significantly better protection against accidental needlestick injuries (NSIs) than early...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading